Clinical Trial Update: Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis [NA]

View source ↗

Summary

A completed clinical trial comparing vancomycin plus moxifloxacin versus vancomycin plus ceftazidime for PD-related peritonitis; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Dialysis-related Peritonitis

Drugs mentioned

• vancomycin + ceftazidime
• vancomycin + moxifloxacin

Snippet

Sponsor: Peking University First Hospital | Conditions: Peritoneal Dialysis Associated Peritonitis | NA | Status: COMPLETED | Results posted: 2020-03-26